No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1738 |
4. Check minimum number of eventsNone |
1738 |
5. Include endpointsNone |
1738 |
6. Filter based on genotype QC (FinnGen only) |
1738 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Recurring oral aphthae
based on the number of shared cases.
Similar with more cases:
- Stomatitis and related lesions
- Recurring oral aphthae, including avohilmo
- Diseases of oral cavity, salivary glands and jaws
- Gastrointestinal diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 14618 | 8065 | 6494 |
| Only index persons | 12873 | 7229 | 5644 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.21 | 0.23 | 0.18 |
| Only index persons | 0.24 | 0.27 | 0.22 |
| Median age at first event (years) | |||
| Whole population | 39.85 | 46.73 | 31.25 |
| Only index persons | 40.83 | 47.06 | 32.84 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1738 | 1096 | 642 |
| Unadjusted period prevalence (%) | 0.34 | 0.37 | 0.28 |
| Median age at first event (years) | 54.89 | 53.05 | 58.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1554
- Matched controls
- 15537
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K12.10
ICD-10 Finland
Stomatitis NOS
758.2
323.0
478
9
K12.00
ICD-10 Finland
Recurrent oral aphthae
136.6
323.0
476
50
K12.18
ICD-10 Finland
Other forms of stomatitis
266.1
323.0
426
22
A07AA02
ATC
nystatin; oral
7.7
115.4
290
449
K12.1
ICD-10 Finland
Other forms of stomatitis
+∞
86.2
82
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
13.3
81.6
147
121
K12.02
ICD-10 Finland
Stomatitis herpetiformis
807.7
79.1
77
*
A01AB09
ATC
miconazole; local oral
4.9
78.7
288
694
EKA10
NOMESCO Finland
Biopsy of cheek
13.9
78.3
138
108
SAA03
NOMESCO Finland
Extended examination of mouth
2.8
77.8
807
4355
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
7.1
73.3
190
298
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
72.5
696
3536
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.5
71.8
199
342
K12.12
ICD-10 Finland
Stomatitis ulcerative
29.5
67.9
92
33
SBA00
NOMESCO Finland
Microbiological examinations
9.0
62.3
137
165
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
9.9
61.5
128
140
H02AB06
ATC
prednisolone; systemic
2.3
54.8
820
5036
J05AB01
ATC
aciclovir; systemic
2.7
52.9
446
2010
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
52.9
758
4530
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.5
49.9
189
460
J02AC01
ATC
fluconazole; systemic
2.3
49.5
725
4331
ECA20
NOMESCO Finland
Biopsy of gingiva
14.7
47.6
81
58
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
43.2
525
2820
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.3
42.5
240
817
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.3
42.2
544
2995
L43.8
ICD-10 Finland
Other lichen planus
9.5
41.8
88
98
R50.9
ICD-10 Finland
Fever, unspecified
2.8
41.7
301
1212
A01AC01
ATC
triamcinolone; local oral
10.2
40.3
81
83
J01DB01
ATC
cefalexin; oral
2.4
38.7
1301
10637
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.2
38.6
222
765
B37.08
ICD-10 Finland
Other candidal stomatitis
20.7
37.6
56
28
K12.01
ICD-10 Finland
Bednar's aphthae
375.9
37.2
37
*
D20
ICPC
Mouth/tongue/lip symptom/complaint
4.4
36.0
136
328
A02BC02
ATC
pantoprazole; systemic
2.0
34.0
1001
7477
J05AB11
ATC
valaciclovir; oral
2.7
33.8
269
1137
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.9
33.3
144
393
XQ802
NOMESCO Finland
Epicutan test
4.7
33.2
118
267
N02AX02
ATC
tramadol; systemic, rectal
2.0
32.9
656
4223
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
32.3
374
1914
K13.78
ICD-10 Finland
Other change in the oral mucosa
7.0
31.8
80
119
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.7
31.5
144
413
K12.0
ICD-10 Finland
Recurrent oral aphthae
61.3
31.2
36
6
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
30.4
1101
8672
J01FF01
ATC
clindamycin; systemic
2.1
30.2
445
2523
J01MA02
ATC
ciprofloxacin; systemic
1.9
29.9
607
3891
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
26.3
29.8
41
16
N02AA05
ATC
oxycodone; systemic
2.5
29.7
265
1186
L04AX01
ATC
azathioprine; systemic
4.1
29.0
118
305
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
28.8
686
4637
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.3
28.5
109
266
A01AB04
ATC
amphotericin B; local oral
3.9
28.4
124
341
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
27.8
28.0
38
14
K13.29
ICD-10 Finland
Indefinite leukoplakia
10.3
27.8
55
55
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
27.0
198
791
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
11.7
26.5
49
43
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
26.5
365
1997
XQ800
NOMESCO Finland
Prick test
2.9
26.1
171
634
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
26.0
362
1987
N03AX16
ATC
pregabalin; oral
2.0
25.9
384
2160
UJF32
NOMESCO Finland
Coloscopy
2.0
25.9
416
2417
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
25.4
258
1227
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
24.7
379
2156
SBB10
NOMESCO Finland
Teeth copy
2.9
24.2
160
597
L03AA02
ATC
filgrastim; parenteral
5.2
24.2
76
151
H02AB07
ATC
prednisone; oral
2.3
24.1
252
1214
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
23.9
581
3883
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.3
23.8
125
399
K12.11
ICD-10 Finland
Stomatitis geographica
243.5
23.7
24
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
23.6
186
773
SXC03
NOMESCO Finland
Other oral or dental procedure
8.4
23.5
52
64
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
8.4
23.5
52
64
A02BC03
ATC
lansoprazole; oral
1.9
23.2
451
2787
K12.13
ICD-10 Finland
Papillary hyperplasia of palate
+∞
23.0
22
*
D07AC01
ATC
betamethasone; topical
1.8
23.0
529
3461
P01AB01
ATC
metronidazole; oral, rectal
1.7
22.3
608
4185
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
22.2
451
2824
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
22.0
175
728
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
22.0
507
3309
WX110
NOMESCO Finland
Local anesthesy
1.7
21.9
1059
8605
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
25.4
21.8
30
12
A02BC01
ATC
omeprazole; systemic
1.8
21.8
432
2679
M35.2
ICD-10 Finland
Behçet disease
116.6
21.6
23
*
SXC05
NOMESCO Finland
Other oral or dental procedure
2.9
21.5
137
499
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
21.0
21.3
31
15
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
50.7
21.1
25
5
EHA10
NOMESCO Finland
Biopsy of palate
10.2
20.9
41
41
K14.61
ICD-10 Finland
Glossodynia
12.6
20.9
37
30
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.3
20.8
78
187
TEA00
NOMESCO Finland
Biopsy of lip
10.0
20.6
41
42
H02AB09
ATC
hydrocortisone; systemic
4.9
20.5
68
144
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
20.4
1005
8115
K13.20
ICD-10 Finland
Idiopathic leukoplakia
13.2
20.2
35
27
H02AB04
ATC
methylprednisolone; systemic
2.1
20.1
242
1237
SBA10
NOMESCO Finland
Measurement of excretion of saliva
8.4
20.0
44
54
J01MA12
ATC
levofloxacin; systemic
2.0
19.9
298
1663
N06AX11
ATC
mirtazapine; oral
1.7
19.7
478
3149
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
19.7
289
1601
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.4
19.5
171
751
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
14.8
19.4
32
22
ZX120
NOMESCO Finland
Intravenous
2.4
19.4
169
740
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
19.2
287
1598
AA1AD
NOMESCO Finland
CT of head and brain
1.8
19.1
363
2206
A02BC05
ATC
esomeprazole; systemic
1.7
18.9
595
4215
N03AX12
ATC
gabapentin; oral
2.0
18.9
255
1364
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
18.8
373
2293
R01AD09
ATC
mometasone; nasal
1.6
18.8
673
4936
EBB10
NOMESCO Finland
Insertion of dental implant
7.5
18.7
44
60
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
18.7
89
264
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
21.1
18.6
27
13
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
18.6
790
6056
127
Kela drug reimbursment
Transplant complication
6.4
18.6
49
79
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
18.4
603
4309
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.8
18.3
123
463
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
18.3
115
416
J01DA01
ATC
[U] cefalexin; systemic
1.6
18.2
919
7348
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.5
18.2
47
74
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
12.5
18.1
32
26
A01AB10
ATC
natamycin; local oral
3.9
18.0
76
204
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
18.0
91
283
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
17.8
236
1249
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
17.8
253
1377
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
17.8
176
819
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.4
17.6
88
272
SXA10
NOMESCO Finland
Epithel biopsy of mouth
7.0
17.5
43
63
K14.60
ICD-10 Finland
Glossopyrosis
13.3
17.5
30
23
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
8.8
17.5
37
43
R13
ICD-10 Finland
Dysphagia
2.7
17.4
125
490
A04AA02
ATC
granisetron; systemic, transdermal
2.9
17.3
111
408
H02AB02
ATC
dexamethasone; systemic
2.3
17.3
172
801
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
17.3
67
167
N06AA09
ATC
amitriptyline; systemic
2.3
17.2
170
792
E0000UV
ATC
NA
1.6
17.2
614
4467
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
17.1
139
583
130
Kela drug reimbursment
Malignant tumour
2.5
16.9
135
561
WW500
NOMESCO Finland
Blood transfusion
3.3
16.9
88
280
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
16.7
174
831
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
16.4
188
936
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
16.4
224
1198
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.4
16.4
43
69
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
16.3
109
411
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.1
16.3
89
294
R03AC02
ATC
salbutamol; inhalant
1.6
16.2
777
6057
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
16.2
168
800
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.1
16.2
51
103
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.5
16.1
47
87
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.5
16.0
75
221
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.3
15.9
81
254
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
15.8
142
630
R06.0
ICD-10 Finland
Dyspnoea
1.7
15.7
361
2311
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.2
15.7
48
94
K12
ICD-10 Finland
Stomatitis and related lesions
16.2
15.2
24
15
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
15.2
270
1589
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
13.2
15.2
26
20
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
6.7
15.1
38
58
N03AE01
ATC
clonazepam; systemic
2.7
15.1
102
387
L43.9
ICD-10 Finland
Lichen planus, unspecified
4.2
15.1
57
139
N02BE01
ATC
paracetamol; systemic, rectal
1.7
14.8
1265
11227
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
14.8
80
263
K50.9
ICD-10 Finland
Crohn disease, unspecified
5.4
14.7
44
84
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.4
14.7
73
225
J01FA09
ATC
clarithromycin; systemic
1.6
14.7
468
3274
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
14.7
119
501
G50.1
ICD-10 Finland
Atypical facial pain
5.9
14.5
40
69
UJF92
NOMESCO Finland
Capsular endoscopy
4.6
14.5
50
112
M79.6
ICD-10 Finland
Pain in limb
1.6
14.4
525
3792
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
14.4
264
1568
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
14.3
639
4849
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
9.2
14.2
29
32
J01MA14
ATC
moxifloxacin; systemic
2.3
14.2
137
628
R42
ICD-10 Finland
Dizziness and giddiness
1.7
14.1
315
1992
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
14.0
686
5307
JN4AD
NOMESCO Finland
Body CT examination
2.4
14.0
123
540
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.7
14.0
60
165
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
13.9
85
302
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.2
13.9
150
727
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.7
13.9
61
171
N05BA04
ATC
oxazepam; oral
1.7
13.8
365
2424
SPAT1263
SPAT
Sampling
1.5
13.7
642
4905
J01AA02
ATC
doxycycline; systemic
1.5
13.7
1098
9457
Z01.2
ICD-10 Finland
Dental examination
1.5
13.7
621
4713
L04AD01
ATC
ciclosporin; systemic
4.6
13.7
47
105
SPF20
NOMESCO Finland
Temporary soling for filling
7.2
13.5
32
45
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
13.5
347
2282
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
13.5
647
4967
L04AA06
ATC
mycophenolic acid; systemic
4.7
13.4
45
98
A07EC02
ATC
mesalazine; oral, rectal
2.7
13.4
95
371
R01AD08
ATC
fluticasone; nasal
1.6
13.4
404
2773
A06AD11
ATC
lactulose; oral
1.9
13.3
204
1137
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
13.3
524
3841
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.6
13.2
25
24
N05CF01
ATC
zopiclone; oral
1.6
13.2
449
3175
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
15.2
13.1
21
14
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.6
13.1
45
101
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
13.0
1010
8577
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
16.9
13.0
20
12
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
13.0
177
945
L12.0
ICD-10 Finland
Bullous pemphigoid
9.4
13.0
26
28
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
19.2
12.9
19
10
A02BA02
ATC
ranitidine; systemic
1.7
12.9
289
1825
D07AD01
ATC
clobetasol; topical
1.8
12.8
228
1336
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
12.8
376
2560
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
12.7
161
833
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
12.7
215
1237
K11.70
ICD-10 Finland
Hypoptyalism
9.7
12.7
25
26
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.4
12.5
111
490
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
12.5
514
3793
WX704
NOMESCO Finland
Intubation
2.3
12.4
118
537
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
4.2
12.3
46
112
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
12.3
324
2141
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.3
12.2
114
514
K14.1
ICD-10 Finland
Geographic tongue
9.7
12.2
24
25
M04AA01
ATC
allopurinol; systemic
2.0
12.2
163
863
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
7.0
12.1
29
42
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
12.0
143
722
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
12.0
59
182
R07.0
ICD-10 Finland
Pain in throat
2.4
12.0
105
462
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.7
11.9
82
316
J01FA10
ATC
azithromycin; systemic
1.5
11.8
866
7193
EAA10
NOMESCO Finland
Excision of lesion of lip
5.5
11.8
34
63
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
11.7
382
2661
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
11.7
237
1448
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
11.7
137
689
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
16.5
11.7
18
11
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.0
11.6
66
223
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.9
11.6
28
41
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
3.7
11.6
49
134
J01FA06
ATC
roxithromycin; oral
1.5
11.6
565
4312
Z01.9
ICD-10 Finland
Special examination, unspecified
2.5
11.6
93
389
R06AE07
ATC
cetirizine; oral
1.5
11.6
633
4945
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
11.5
410
2914
K50.8
ICD-10 Finland
Other Crohn disease
4.4
11.4
40
92
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.4
11.4
29
46
N06AX16
ATC
venlafaxine; oral
1.8
11.3
193
1113
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
11.9
11.3
20
17
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
11.3
770
6278
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
8.4
11.3
24
29
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.6
11.3
38
84
A04AA01
ATC
ondansetron; systemic, rectal
2.3
11.3
110
507
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.0
11.2
64
218
WX720
NOMESCO Finland
Own respiration
2.9
11.2
69
247
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
11.2
151
802
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
11.1
315
2113
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
20.2
11.1
16
8
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.4
11.1
39
90
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.9
11.1
45
119
GBB00
NOMESCO Finland
Tracheostomy
6.1
11.1
29
48
L04AA01
ATC
[U] ciclosporin; systemic
4.8
11.1
36
77
M25.5
ICD-10 Finland
Pain in joint
1.5
11.0
399
2848
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.0
812
6717
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.9
308
2064
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
15.6
10.8
17
11
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
10.8
158
866
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
10.7
234
1460
EDB00
NOMESCO Finland
Partial excision of mandible
28.2
10.7
14
5
M01AE02
ATC
naproxen; oral, rectal
1.4
10.6
817
6790
SPAT1254
SPAT
Administration of medicine
1.7
10.6
237
1489
WX002
NOMESCO Finland
Sedation and analgesia
1.6
10.5
274
1797
M03BX02
ATC
tizanidine; oral
1.4
10.5
836
6983
C03CA01
ATC
furosemide; systemic
1.6
10.5
359
2520
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
14.3
10.5
17
12
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
10.5
113
549
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
10.5
152
831
SPF30
NOMESCO Finland
Soling for prothesis
3.9
10.4
41
106
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
10.4
240
1521
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
10.4
370
2625
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
10.4
143
765
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
10.3
118
586
EB1WA
NOMESCO Finland
NA
8.2
10.3
22
27
J37.0
ICD-10 Finland
Chronic laryngitis
3.0
10.3
57
193
A07AA09
ATC
vancomycin; oral
4.8
10.3
33
70
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
10.3
189
1117
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
10.2
118
590
JN4BD
NOMESCO Finland
Extensive body CT
1.9
10.2
157
872
R21
ICPC
Throat symptom/complaint
1.6
10.2
308
2100
R02
ICPC
Shortness of breath/dyspnoea
1.8
10.1
169
971
L03AA13
ATC
pegfilgrastim; parenteral
2.8
10.1
64
236
EBB15
NOMESCO Finland
Insertion of dental implant abutment
6.9
10.1
24
35
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
10.1
10.0
19
19
EHB00
NOMESCO Finland
Excision of lesion of palate
14.7
10.0
16
11
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
10.0
120
609
B37.0
ICD-10 Finland
Candidal stomatitis
5.6
10.0
28
51
R4190
NOMESCO Finland
Nutritional therapy
2.7
9.9
68
263
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
9.9
77
318
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
9.8
177
1039
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
9.8
80
340
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.0
9.8
123
635
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
26.2
9.8
13
5
J01CA04
ATC
amoxicillin; systemic
1.5
9.8
1202
10833
R53
ICD-10 Finland
Malaise and fatigue
1.6
9.8
287
1936
R51.80
ICD-10 Finland
Headache
1.7
9.8
217
1359
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
9.7
155
873
K07.60
ICD-10 Finland
Snapping jaw
2.5
9.7
77
323
M79.1
ICD-10 Finland
Myalgia
1.7
9.7
191
1152
P01BA02
ATC
hydroxychloroquine; oral
2.0
9.7
126
662
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
55.3
9.7
11
*
A03
ICPC
Fever
1.7
9.6
233
1495
L01
ICPC
Neck symptom/complaint
1.7
9.6
195
1187
R51.81
ICD-10 Finland
Facial pain NOS
3.5
9.6
44
130
K03.66
ICD-10 Finland
Tooth plaque
2.1
9.6
110
546
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
9.6
223
1415
WW300
NOMESCO Finland
Transfer of autologic stem cells
11.4
9.6
17
15
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.6
9.5
41
115
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
15.1
9.5
15
10
EBA00
NOMESCO Finland
Extraction of tooth
1.5
9.5
467
3538
L12.1
ICD-10 Finland
Cicatricial pemphigoid
100.6
9.4
10
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.0
9.4
51
171
N05AH04
ATC
quetiapine; oral
1.7
9.4
226
1451
N05CD07
ATC
temazepam; oral
1.8
9.3
164
955
X58
ICD-10 Finland
Exposure to other specified factors
1.7
9.3
194
1190
M54.5
ICD-10 Finland
Low back pain
1.5
9.3
446
3360
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.6
9.3
31
69
R02AD02
ATC
lidocaine; local oral
3.6
9.3
40
113
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.3
9.2
81
358
R4110
NOMESCO Finland
Physiotherapy
1.5
9.2
356
2564
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
9.2
101
496
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.3
9.1
86
392
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
9.1
176
1059
UKC02
NOMESCO Finland
Cystoscopy
1.7
9.1
203
1275
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
9.1
264
1779
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
9.1
397
2931
J02AC02
ATC
itraconazole; systemic
1.6
9.0
236
1543
WF002
NOMESCO Finland
Radical radiotherapy
2.5
9.0
69
285
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
9.0
102
506
B02.9
ICD-10 Finland
Zoster without complication
2.3
8.9
83
378
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
8.9
67
271
UJC01
NOMESCO Finland
Scopy of lower throat
5.5
8.9
25
46
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
8.9
190
1177
L03
ICPC
Low back symptom/complaint
1.5
8.9
329
2345
J01EA01
ATC
trimethoprim; systemic
1.5
8.8
351
2538
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
8.8
70
293
N06AB04
ATC
citalopram; systemic
1.6
8.8
284
1958
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
8.8
186
1147
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
8.8
173
1045
J04BA02
ATC
dapsone; oral
8.7
8.8
18
21
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
8.8
194
1214
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
8.8
84
388
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.7
8.7
28
60
WW200
NOMESCO Finland
Immunization
2.9
8.7
51
180
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
8.7
102
515
R03BB04
ATC
tiotropium bromide; inhalant
1.9
8.7
128
705
S02CA02
ATC
flumetasone and antiinfectives; otic
2.3
8.6
80
362
A05AA02
ATC
ursodeoxycholic acid; oral
3.9
8.6
34
89
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
8.3
8.6
18
22
XG410
NOMESCO Finland
Flow-volume spirometry
2.4
8.6
71
304
R07.3
ICD-10 Finland
Other chest pain
1.9
8.5
127
701
D11
ICPC
Diarrhoea
1.8
8.5
159
946
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
27.7
8.5
11
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.1
8.5
31
76
EJ2S1
NOMESCO Finland
Photography of oral mucosa
20.1
8.5
12
6
ECA30
NOMESCO Finland
Excision of lesion of gingiva
4.7
8.4
27
58
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.6
8.4
59
233
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.4
8.4
70
300
SPAT1310
SPAT
Counselling related to known health issue
1.4
8.4
463
3570
K30
ICD-10 Finland
Functional dyspepsia
1.8
8.3
145
841
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.1
8.3
43
140
M54.2
ICD-10 Finland
Cervicalgia
2.0
8.3
103
528
A01
ICPC
Pain general/multiple sites
1.9
8.3
114
612
D83
ICPC
Mouth/tongue/lip disease
8.6
8.3
17
20
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
8.3
80
369
N05BA01
ATC
diazepam; systemic, rectal
1.7
8.3
181
1127
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
8.3
109
574
R03DC03
ATC
montelukast; oral
1.6
8.2
219
1441
SPAT1255
SPAT
Intravenous administration of medicine
2.1
8.2
89
432
6BA02
NOMESCO Finland
NA
14.5
8.2
13
9
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
6.5
8.2
20
31
R05
ICD-10 Finland
Cough
1.5
8.2
274
1905
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.6
8.2
59
234
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.5
8.1
59
237
TAB00
NOMESCO Finland
Lumbar puncture
2.3
8.1
71
314
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
8.2
8.1
17
21
K92.1
ICD-10 Finland
Melaena
2.3
8.1
74
335
EKB00
NOMESCO Finland
Excision of lesion of cheek
9.0
8.0
16
18
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
8.0
111
595
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.1
8.0
86
419
R74
ICPC
Upper respiratory infection acute
1.4
8.0
401
3034
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
8.0
248
1695
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.6
8.0
56
222
G44.2
ICD-10 Finland
Tension-type headache
1.6
7.9
187
1194
R11
ICD-10 Finland
Nausea and vomiting
1.8
7.9
123
690
J03.0
ICD-10 Finland
Streptococcal tonsillitis
2.7
7.8
52
200
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.9
7.8
106
568
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.2
7.8
28
68
K14.9
ICD-10 Finland
Disease of tongue, unspecified
10.8
7.8
14
13
R52.2
ICD-10 Finland
Other chronic pain
2.6
7.8
55
219
L17
ICPC
Foot/toe symptom/complaint
1.5
7.8
347
2562
R03BA05
ATC
fluticasone; inhalant
1.5
7.8
254
1755
SPAT1260
SPAT
Consultation of another employee
1.5
7.7
244
1671
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
7.7
153
925
K12.14
ICD-10 Finland
Contact stomatitis
45.2
7.7
9
*
N06AX21
ATC
duloxetine; oral
1.7
7.7
148
890
SPA02
NOMESCO Finland
Preparation for dental prosthetics
3.3
7.7
36
110
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.6
7.7
32
89
A28
ICPC
Limited function/disability NOS
1.6
7.7
192
1242
A03FA02
ATC
cisapride; oral, rectal
1.9
7.7
110
599
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
7.6
78
369
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
7.6
137
804
L12
ICPC
Hand/finger symptom/complaint
1.6
7.6
208
1374
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
18.4
7.6
11
6
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.6
7.6
52
201
L43.3
ICD-10 Finland
Subacute (active) lichen planus
11.9
7.6
13
11
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.5
7.6
57
235
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.3
7.5
70
318
J46
ICD-10 Finland
Status asthmaticus
2.7
7.5
48
178
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
7.5
227
1538
N05CF02
ATC
zolpidem; oral
1.6
7.5
227
1541
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
7.5
114
634
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.1
7.4
77
369
A07EA06
ATC
budesonide; oral, local oral
2.5
7.4
56
231
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
7.4
103
556
K59.0
ICD-10 Finland
Constipation
2.1
7.4
82
405
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
7.4
396
3022
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
7.4
55
224
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
6.5
7.4
18
28
M79.7
ICD-10 Finland
Fibromyalgia
2.6
7.4
51
198
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
7.4
92
475
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
7.7
7.4
16
21
L43.0
ICD-10 Finland
Hypertrophic lichen planus
5.3
7.4
21
40
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
13.4
7.4
12
9
ZXA00
NOMESCO Finland
Right side
1.4
7.4
351
2624
M02AA07
ATC
piroxicam; topical
1.4
7.4
472
3720
A08
ICPC
Swelling
2.4
7.3
61
265
C05AA08
ATC
fluocortolone; rectal, topical
1.6
7.3
184
1191
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.8
7.3
43
154
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
7.3
105
572
N30.0
ICD-10 Finland
Acute cystitis
1.6
7.3
194
1274
R05
ICPC
Cough
1.5
7.3
307
2238
R03AC03
ATC
terbutaline; inhalant
1.6
7.3
179
1154
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
7.3
116
655
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
6.3
7.2
18
29
R03BA01
ATC
beclometasone; inhalant
1.6
7.2
185
1204
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.7
7.2
47
179
R06AX22
ATC
ebastine; oral
1.6
7.2
218
1478
TPX15
NOMESCO Finland
Removal of vascular injection port
7.3
7.2
16
22
L28
ICPC
Limited function/disability (L)
1.6
7.2
193
1270
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
7.2
53
215
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
4.8
7.2
22
46
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
30.1
7.1
9
*
A04
ICPC
Weakness/tiredness general
1.6
7.1
181
1176
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
7.1
133
792
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
7.1
291
2108
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.6
7.1
30
85
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.3
7.1
20
38
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.7
7.1
29
80
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
3.7
7.1
29
80
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.9
7.1
27
70
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.1
879
7678
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
7.1
726
6165
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
7.0
88
458
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
10.1
7.0
13
13
C07AA05
ATC
propranolol; systemic
1.5
7.0
255
1801
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
7.0
59
258
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.7
7.0
142
868
R06AE09
ATC
levocetirizine; oral
1.6
7.0
200
1336
K04.08
ICD-10 Finland
Other specified pulpit
2.1
7.0
78
385
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
4.0
7.0
26
66
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
7.0
217
1482
ZXC10
NOMESCO Finland
Use of laser
3.1
7.0
36
119
TGC00
NOMESCO Finland
Bronchial lavation
2.9
6.9
40
140
J01.4
ICD-10 Finland
Acute pansinusitis
6.4
6.9
17
27
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
6.9
91
482
R33
ICD-10 Finland
Retention of urine
2.0
6.9
89
469
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
13.8
6.9
11
8
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
6.9
184
1208
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.6
6.9
166
1064
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
6.9
284
2060
B07.9
ICD-10 Finland
Verruca simplex
2.5
6.9
51
207
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
6.8
60
266
K05.30
ICD-10 Finland
Periodontitis complex
1.6
6.8
161
1026
4AA12
NOMESCO Finland
NA
8.3
6.8
14
17
K03.00
ICD-10 Finland
Approximal wear
2.1
6.8
70
334
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
6.8
167
1075
R52.9
ICD-10 Finland
Pain, unspecified
1.8
6.8
116
672
GD6AD
NOMESCO Finland
CT of chest and neck
11.0
6.8
12
11
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.5
6.8
29
83
D07AA02
ATC
hydrocortisone; topical
1.6
6.8
198
1331
L12.8
ICD-10 Finland
Other pemphigoid
40.2
6.8
8
*
R06AX27
ATC
desloratadine; oral
1.4
6.8
365
2788
R01AD01
ATC
beclometasone; nasal
1.6
6.8
196
1315
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
16.8
6.7
10
6
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
6.7
72
351
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.2
6.7
32
100
K13.00
ICD-10 Finland
Cheilitis NOS
7.2
6.7
15
21
L30.8
ICD-10 Finland
Other specified dermatitis
3.0
6.7
35
117
B00.11
ICD-10 Finland
Herpes simplex labialis
3.7
6.7
27
74
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.7
6.7
137
840
WX892
NOMESCO Finland
Monitored bed care
1.8
6.7
102
569
M01AH03
ATC
valdecoxib; oral
2.0
6.7
83
432
N06AB10
ATC
escitalopram; oral
1.5
6.7
259
1858
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.7
6.6
43
163
UJC02
NOMESCO Finland
Rigid oesophagoscopy
5.2
6.6
19
37
A46
ICD-10 Finland
Erysipelas
1.6
6.6
162
1044
R03BA02
ATC
budesonide; inhalant
1.5
6.6
227
1585
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
6.6
130
789
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.3
6.6
11
9
N06AX26
ATC
vortioxetine; oral
2.1
6.6
75
374
ZX121
NOMESCO Finland
Central venous catheter
8.7
6.6
13
15
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
6.5
373
2871
WW409
NOMESCO Finland
Other aferesis
10.1
6.5
12
12
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
6.5
101
567
M01AH05
ATC
etoricoxib; oral
1.3
6.5
751
6456
N03AF01
ATC
carbamazepine; oral, rectal
2.1
6.5
68
328
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.1
6.5
68
328
R81
ICPC
Pneumonia
2.5
6.5
49
201
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
4.2
6.5
23
56
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.5
6.5
49
202
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.5
383
2967
N17
ICPC
Vertigo/dizziness
1.7
6.5
146
918
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
6.5
91
495
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.7
6.5
17
30
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
70.1
6.4
7
*
S01.50
ICD-10 Finland
Open wound in oral cavity
4.3
6.4
22
52
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
4.3
6.4
22
52
J01FA15
ATC
telithromycin; oral
1.7
6.4
125
756
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.4
394
3072
L50.0
ICD-10 Finland
Allergic urticaria
2.6
6.4
45
178
K14.09
ICD-10 Finland
Glossit UNS
14.4
6.4
10
7
ZX131
NOMESCO Finland
Intrathecal
14.4
6.4
10
7
S04
ICPC
Lump/swelling localized
1.7
6.4
121
724
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
6.4
65
311
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.9
6.4
24
62
D06BX01
ATC
metronidazole; topical
1.7
6.4
134
825
EMAK
NOMESCO Finland
NA
2.2
6.4
58
265
ECB20
NOMESCO Finland
Oral alveoplasty
4.4
6.3
21
48
N06AB06
ATC
sertraline; oral
1.6
6.3
145
915
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
6.3
67
326
SPE00
NOMESCO Finland
Fitting and preparation of metal structure partial teeth prosthesis
3.2
6.3
30
94
ZX112
NOMESCO Finland
Subcutaneous
2.9
6.3
36
125
L01BB02
ATC
mercaptopurine; oral
4.0
6.3
23
58
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.9
6.3
24
63
L16
ICPC
Ankle symptom/complaint
1.7
6.3
135
841
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
6.3
431
3422
S29
ICPC
Skin symptom/complaint other
1.5
6.3
223
1570
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
6.2
258
1872
J01DA08
ATC
[U] cefaclor; oral
1.6
6.2
167
1100
K11.2
ICD-10 Finland
Sialoadenitis
2.4
6.2
49
209
G01AF04
ATC
miconazole; vaginal
2.1
6.2
69
344
M01AG02
ATC
tolfenamic acid; oral, rectal
1.5
6.2
196
1343
WX872
NOMESCO Finland
Intensive care
2.1
6.2
66
322
H01
ICPC
Ear pain/earache
1.6
6.2
151
969
E000001
ATC
NA
1.4
6.2
279
2058
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.2
6.2
58
266
K08.3
ICD-10 Finland
Retained dental root
1.9
6.2
85
460
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.2
566
4699
WZA90
NOMESCO Finland
Other doctors statement
1.4
6.1
317
2397
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
7.7
6.1
13
17
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
6.1
76
393
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
6.1
58
269
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.4
6.1
47
197
N06AB05
ATC
paroxetine; oral
1.9
6.1
82
437
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
6.1
130
807
N06AB03
ATC
fluoxetine; oral
1.6
6.1
173
1157
A03CA02
ATC
clidinium and psycholeptics; oral
1.9
6.1
78
411
UJD02
NOMESCO Finland
Gastroscopy
2.1
6.0
67
333
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
10.1
6.0
11
11
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
6.0
374
2920
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
160
190
9.17
126.15
2.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
124
136
9.74
103.61
1.6
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
147
283
5.58
73.48
8.2
5.2
iu/ml
281.4
321.3
0.11
25
35
(42870588) Differential panel, method unspecified - Blood
859
5003
2.42
69.88
12.6
5.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1130
7550
2.42
65.58
12.6
6.0
e9/l
0.2
0.2
0.31
1023
6600
(3006315) Basophils [#/volume] in Blood
1100
7314
2.37
63.77
11.5
5.8
e9/l
0.0
0.0
0.39
994
6295
(3001604) Monocytes [#/volume] in Blood
1096
7288
2.36
63.34
11.5
5.7
e9/l
0.6
0.6
0.10
988
6266
(3019198) Lymphocytes [#/volume] in Blood
1116
7499
2.36
62.63
11.4
5.8
e9/l
1.8
2.0
2.44
1013
6582
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
78
94
8.64
60.31
1.8
1.4
u/ml
17.4
20.9
0.30
20
18
(3022096) Basophils/100 leukocytes in Blood
1021
6692
2.27
59.54
11.9
5.9
%
0.7
0.7
0.21
976
6259
(3019069) Monocytes/100 leukocytes in Blood
1046
6933
2.28
59.24
12.5
6.1
%
8.8
8.6
1.05
1000
6500
(3006504) Eosinophils/100 leukocytes in Blood
1042
6902
2.27
59.01
11.9
5.9
%
2.8
2.8
0.44
998
6434
(3000494) Fungus identified in Specimen by Culture
386
1654
2.71
59.01
1.9
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
72
81
9.23
58.73
1.3
1.3
titre
56.0
77.5
—
5
12
(3018010) Neutrophils/100 leukocytes in Blood
1049
7032
2.24
56.78
11.7
5.7
%
56.6
56.6
0.02
1000
6594
(3002030) Lymphocytes/100 leukocytes in Blood
1056
7126
2.23
55.84
12.1
5.9
%
28.1
28.6
0.67
1007
6660
(3024561) Albumin [Mass/volume] in Serum or Plasma
932
6011
2.19
54.89
9.5
4.8
g/l
35.1
35.8
2.84
869
5583
(3013650) Neutrophils [#/volume] in Blood by Automated count
1189
8467
2.28
54.36
19.0
8.7
e9/l
4.0
4.0
0.43
1083
7389
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
113
225
5.30
54.21
5.4
3.1
u/ml
46758.4
1951.8
0.47
12
15
(3005719) IgG [Mass/volume] in Serum or Plasma
283
1085
2.92
53.02
4.5
2.8
g/l
9.9
10.4
1.11
264
991
(3023368) Bacteria identified in Blood by Culture
652
3689
2.23
52.95
6.5
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1059
7251
2.18
52.65
11.3
6.1
umol/l
10.3
12.0
2.82
1001
6867
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
261
981
2.95
50.56
2.2
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
451
2287
2.31
46.78
2.8
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1354
10481
2.32
46.16
6.0
4.0
mm/h
13.3
11.9
2.79
1260
9691
(3007853) Bacteria identified in Skin by Aerobe culture
362
1691
2.44
45.09
2.0
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
80
139
5.98
44.35
4.1
2.2
e9/l
1.2
1.3
0.45
51
84
(3012095) Magnesium [Moles/volume] in Serum or Plasma
438
2242
2.27
44.10
8.1
3.5
mmol/l
0.8
0.8
2.99
402
2107
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
998
7017
1.99
42.04
13.1
6.8
mmol/l
1.2
1.2
1.50
872
5967
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
67
103
6.73
41.87
4.3
2.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
386
1915
2.31
41.59
1.5
1.3
titre
436.9
502.8
0.53
90
394
(3028026) IgM [Mass/volume] in Serum or Plasma
223
853
2.85
41.46
2.4
1.8
g/l
1.1
1.4
1.87
207
784
(3048689) Calprotectin [Mass/mass] in Stool
375
1843
2.32
41.28
3.4
2.4
ug/g
136.5
118.9
0.36
317
1444
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
67
105
6.60
41.11
4.6
2.2
e9/l
0.2
0.2
1.16
55
90
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
68
109
6.45
40.83
4.5
2.2
e6/l
490.4
557.1
0.30
55
91
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
924
6399
1.95
39.87
11.4
6.2
mmol/l
1.2
1.2
2.03
851
5816
(1175426) CD3 cells/100 lymphocytes in Blood
67
112
6.18
38.60
4.3
2.2
%
75.7
71.0
1.42
62
107
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
318
1506
2.36
37.85
8.5
4.0
u/l
265.0
245.3
0.47
307
1422
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
66
111
6.14
37.79
4.3
2.2
%
11.8
11.6
0.04
47
63
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1353
10810
2.14
37.37
13.3
7.2
u/l
80.8
79.8
0.22
1284
10145
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
110
299
3.86
35.53
1.7
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
327
1608
2.27
35.46
2.7
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
104
275
3.96
34.91
1.7
1.5
u/ml
183.4
106.8
0.92
18
48
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
323
1614
2.23
33.54
2.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
380
2025
2.12
33.53
2.3
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
51
78
6.71
32.00
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
658
4313
1.85
31.36
3.9
2.5
u/l
53.5
57.4
2.06
604
3977
(3007164) IgA [Mass/volume] in Serum or Plasma
504
3042
1.93
31.02
2.0
1.5
g/l
2.2
2.3
0.61
323
1794
(3028433) Virus identified in Specimen by Culture
42
55
7.80
30.24
1.2
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
41
54
7.75
29.38
5.9
2.4
e6/l
211.8
313.4
0.55
22
32
(3022948) Iron [Moles/volume] in Serum or Plasma
383
2144
2.01
29.12
2.7
2.4
umol/l
12.7
13.1
0.39
361
1985
(3039000) Anion gap in Blood
99
287
3.60
29.09
10.5
9.1
mmol/l
10.8
11.3
0.62
90
260
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
298
1521
2.16
29.03
8.8
8.2
kpa
5.1
5.1
0.24
285
1461
(3027801) Oxygen [Partial pressure] in Arterial blood
298
1522
2.16
28.98
8.8
8.1
kpa
13.1
12.4
1.11
286
1464
(3018572) Chloride [Moles/volume] in Blood
99
288
3.58
28.94
10.4
9.1
mmol/l
105.1
105.6
0.51
90
261
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
126
432
3.07
28.27
2.1
1.6
g/l
0.2
0.2
0.06
121
410
(3001964) Herpes simplex virus Ag [Presence] in Specimen
35
40
8.91
28.10
1.5
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
273
1363
2.19
28.05
9.1
8.6
%
95.8
95.5
0.22
261
1318
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
173
706
2.61
28.01
12.3
11.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
272
1360
2.19
27.84
2.8
2.2
nmol/l
357.9
370.8
0.49
244
1245
(3003396) Base excess in Arterial blood by calculation
294
1517
2.13
27.76
8.8
8.2
mmol/l
1.1
1.1
0.09
237
1201
(3003458) Phosphate [Moles/volume] in Serum or Plasma
350
1927
2.02
27.75
11.0
5.6
mmol/l
1.1
1.1
0.04
322
1781
(3009445) Proteinase 3 Ab [Units/volume] in Serum
151
582
2.75
27.36
1.6
1.4
u/ml
3.4
11.1
—
5
15
(3032080) INR in Blood by Coagulation assay
770
5457
1.74
27.03
10.9
8.9
inr
1.2
1.2
1.54
182
1566
(3017143) Hepatitis C virus Ab [Presence] in Serum
313
1671
2.06
26.94
1.6
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
567
3690
1.80
26.72
3.1
2.2
mg/l
3.0
3.0
0.00
491
3122
(3004789) Transferrin [Mass/volume] in Serum or Plasma
352
1967
1.99
26.66
2.8
2.4
g/l
2.4
2.4
0.01
330
1824
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
826
5988
1.72
26.57
3.0
2.3
nmol/l
77.0
76.6
0.14
746
5368
(3019060) Gas panel - Arterial blood
196
870
2.41
26.51
6.6
5.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
669
4587
1.75
26.20
6.5
3.1
u/l
30.5
32.6
0.89
636
4380
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
140
531
2.78
26.14
8.7
6.2
%
1.8
1.6
1.40
131
500
(3019309) Folate [Moles/volume] in Red Blood Cells
420
2507
1.89
26.08
1.9
1.7
nmol/l
1221.9
1172.4
0.35
332
1899
(3002173) Hemoglobin [Mass/volume] in Arterial blood
252
1253
2.18
26.05
9.6
8.7
g/l
117.0
120.6
2.02
238
1212
(3037467) Urinalysis macro (dipstick) panel - Urine
1216
9853
1.78
25.81
6.6
4.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
117
406
3.02
25.69
9.7
7.7
mmol/l
1.2
1.3
0.71
108
359
(3015171) Extractable nuclear Ab [Units/volume] in Serum
140
540
2.73
25.30
1.3
1.2
u/ml
0.3
0.9
—
8
37
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
785
5668
1.70
25.19
2.3
2.0
pmol/l
96.9
95.8
0.27
438
2896
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
112
384
3.05
25.11
1.7
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
142
555
2.70
25.01
1.7
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
262
1344
2.12
24.95
3.5
2.4
g/l
0.2
0.2
0.07
240
1265
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
296
1600
2.02
24.44
6.0
2.8
umol/l
8.9
7.8
0.28
250
1377
(3015377) Calcium [Moles/volume] in Serum or Plasma
685
4800
1.70
24.32
4.6
3.4
mmol/l
2.3
2.4
1.26
593
4218
(3020717) Zinc [Moles/volume] in Serum or Plasma
45
81
5.68
24.04
1.6
1.5
umol/l
18.1
20.4
0.23
45
76
(3013826) Glucose [Moles/volume] in Serum or Plasma
1049
8240
1.69
24.02
9.0
4.9
mmol/l
6.8
6.6
0.57
997
7679
(3008152) Bicarbonate [Moles/volume] in Arterial blood
182
820
2.36
23.73
8.4
7.8
mmol/l
24.6
24.5
0.12
170
770
(3007930) Methemoglobin/Hemoglobin.total in Blood
134
524
2.69
23.56
9.0
6.2
%
1.0
0.9
1.55
125
493
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
99
328
3.14
23.53
1.8
1.3
—
—
—
0
0
(44790048)
67
172
4.01
23.42
2.5
1.5
—
—
—
0
0
(44790047)
67
172
4.01
23.42
2.5
1.5
—
—
—
0
0
(44806118)
67
172
4.01
23.42
2.5
1.5
—
—
—
0
0
(44790049)
67
172
4.01
23.42
2.5
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1167
9465
1.71
23.37
6.4
4.5
e6/l
960.9
2156.0
0.70
12
140
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
50
103
4.97
23.03
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
105
365
3.00
22.97
1.2
1.2
u/ml
4.0
11.0
1.03
15
59
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
321
1829
1.93
22.63
2.9
2.5
%
21.3
22.8
0.94
264
1578
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
103
359
2.99
22.43
1.2
1.2
u/ml
6.9
3.2
—
9
36
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
45
88
5.22
21.99
2.6
2.7
%
36.3
42.0
0.78
24
28
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
598
4131
1.68
21.83
2.4
2.2
u/l
171.6
242.3
1.12
561
3885
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
460
2962
1.75
21.69
1.8
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
238
1238
2.07
21.68
15.3
7.1
mmol/l
8.0
9.0
1.57
225
1187
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1134
9219
1.66
21.56
5.2
3.1
u/l
46.5
46.0
0.06
1059
8619
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
100
351
2.96
21.51
2.8
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
216
1088
2.13
21.42
3.7
2.8
g/l
65.2
66.4
1.34
202
997
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
98
342
2.98
21.30
2.9
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
37
62
6.08
21.26
1.4
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
73
213
3.53
21.25
2.5
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
26
29
9.09
21.22
1.9
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
761
5635
1.62
20.87
2.4
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
870
6667
1.61
20.63
5.9
4.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
434
2785
1.74
20.55
2.0
1.9
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
49
110
4.55
20.39
4.4
2.1
e6/l
572.8
712.1
0.53
16
40
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
64
176
3.74
20.34
5.8
6.0
mg/l
11.1
11.4
0.14
56
159
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
91
315
2.99
20.06
1.8
1.3
u/ml
262.6
246.7
0.09
51
180
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
510
3440
1.68
20.04
1.5
1.3
u/ml
2.3
1.8
0.23
102
880
(3023520) Reticulocytes [#/volume] in Blood
220
1143
2.06
20.04
4.9
2.7
e9/l
66.9
71.1
0.82
175
865
(3024139) IgG subclass 3 [Mass/volume] in Serum
56
142
4.04
19.93
1.5
1.3
g/l
0.4
0.4
0.12
46
99
(3028192) IgG subclass 2 [Mass/volume] in Serum
56
142
4.04
19.93
1.5
1.3
g/l
3.0
2.7
0.58
46
99
(3027135) IgG subclass 1 [Mass/volume] in Serum
56
142
4.04
19.93
1.5
1.3
g/l
6.1
6.7
0.66
46
100
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
407
2592
1.74
19.69
5.0
3.7
ng/l
226.2
411.5
0.96
307
1970
(4062490)
56
144
3.99
19.56
1.5
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
24
27
9.00
19.45
3.1
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
73
226
3.33
19.40
1.6
1.6
g/l
0.8
0.8
0.06
57
173
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
237
3.26
19.29
1.8
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
472
3147
1.69
19.25
3.1
1.8
mg/l
1.2
1.2
0.01
362
2375
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
113
451
2.61
19.06
1.9
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
109
428
2.65
18.99
3.2
2.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
835
6421
1.58
18.91
3.7
2.7
ug/l
140.4
111.4
2.04
768
5929
(3027945) Reticulocytes/100 erythrocytes in Blood
273
1560
1.89
18.83
5.8
2.8
%
1.7
1.8
0.69
243
1399
(40758558) Short blood count panel - Blood
540
3752
1.64
18.66
14.9
6.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
179
887
2.13
18.43
2.9
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
126
541
2.43
18.23
2.2
2.0
ug/l
1.6
1.8
0.07
108
475
(3026008) Bacteria identified in Urine by Culture
611
4402
1.60
18.07
3.7
3.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
23
28
8.31
17.53
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1297
11155
1.64
17.42
4.8
4.0
pmol/l
14.8
14.7
0.09
1184
10159
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
206
1099
1.99
17.35
4.0
2.9
ng/l
164.4
197.5
0.52
181
1007
(36660697) Celiac disease serology panel - Serum
225
1239
1.94
17.28
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1575
14338
2.05
17.14
27.4
13.6
mg/l
22.8
23.3
0.32
1351
11240
(3021879) Hepatitis B virus core Ab [Presence] in Serum
202
1077
1.99
17.03
1.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
170
855
2.10
16.81
1.9
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
340
2142
1.73
16.81
4.0
2.2
s
29.6
29.6
0.06
332
2072
(3018418) pH of Serum or Plasma
568
4106
1.57
16.15
5.9
3.8
ph
7.4
7.4
1.70
88
776
(3026493) Urate [Moles/volume] in Serum or Plasma
495
3472
1.60
16.00
4.5
2.6
umol/l
2512.7
5542.2
1.37
428
3018
(40768443) Skin Pathology biopsy report
131
606
2.26
15.97
1.3
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
56
167
3.43
15.81
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
52
149
3.57
15.60
1.7
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
15
12
12.60
15.15
1.1
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
432
2981
1.60
14.78
3.4
2.5
e6/l
5.5
6.6
0.96
392
2604
(3026782) Osmolality of Urine
410
2800
1.61
14.63
3.6
2.7
mosm/kgh2o
541.0
551.9
0.41
370
2375
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
77
290
2.73
14.59
1.2
1.2
u/ml
36.8
43.1
—
9
27
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
492
2.32
14.52
3.5
2.6
g/l
7.2
7.4
0.33
68
381
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
492
2.32
14.52
3.5
2.6
g/l
3.6
3.7
0.29
65
364
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
492
2.32
14.52
3.5
2.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
34
75
4.60
14.49
1.5
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
345
2265
1.65
14.40
1.7
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
450
3153
1.58
14.36
6.7
4.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
14
11
12.82
14.26
7.1
4.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
666
5091
1.50
14.19
4.4
3.6
ng/l
315.7
44.5
0.45
465
3401
(3002582) Erythrocytes [#/volume] in Urine
576
4278
1.52
14.07
4.6
3.2
e6/l
49.4
74.3
0.62
466
3275
(3002032) Base excess in Venous blood by calculation
231
1370
1.79
13.92
13.8
3.8
mmol/l
2.1
1.7
0.70
190
1081
(3003181) Sodium [Moles/volume] in Urine
68
246
2.84
13.90
1.8
1.5
mmol/l
66.9
64.4
0.19
52
201
(3030467) Casts [#/volume] in Urine by Automated count
535
3923
1.53
13.83
4.4
3.1
e6/l
0.3
0.4
0.77
428
2945
(3025941) Bacteria identified in Stool by Culture
150
775
2.02
13.76
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
77
299
2.65
13.76
1.7
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1123
9563
1.49
13.71
3.6
3.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
461
2.31
13.58
3.7
2.6
g/l
3.0
3.1
0.69
67
373
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
41
110
3.79
13.56
1.6
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
12
11.75
13.54
9.9
3.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
459
3268
1.55
13.53
1.6
1.5
nmol/l
20.3
20.8
0.29
390
2776
(3021447) Carbon dioxide [Partial pressure] in Venous blood
230
1378
1.77
13.37
14.0
3.8
kpa
5.8
5.8
0.10
222
1336
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1459
13188
1.66
13.35
5.8
4.8
mu/l
5.2
2.0
0.80
1337
12107
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
24
42
5.78
13.22
1.3
1.1
%
88.7
85.9
0.14
24
42
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
24
42
5.78
13.22
1.3
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
81
330
2.53
13.14
2.9
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
59
204
2.96
13.10
1.9
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
173
957
1.90
13.01
1.4
1.3
u/ml
155.9
232.7
0.75
159
879
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
51
163
3.19
12.94
3.0
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
41
114
3.66
12.89
1.4
1.2
titre
101.8
163.3
0.39
11
18
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
460
2.27
12.80
3.3
2.6
g/l
9.7
10.3
0.53
74
400
(40768797) Stomach Pathology biopsy report
296
1926
1.65
12.67
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
185
1057
1.84
12.57
5.5
3.9
%
0.7
0.5
0.34
43
237
(3000991) Gas panel - Venous blood
209
1240
1.78
12.53
14.1
8.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
266
1688
1.68
12.53
13.0
6.9
mmol/l
104.4
104.5
0.02
258
1647
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
84
357
2.42
12.46
2.1
2.1
mg/l
10.7
11.8
0.66
74
328
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
46
142
3.30
12.36
3.2
1.6
—
—
—
0
0
(4035726)
205
1216
1.78
12.30
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
53
179
3.02
12.27
1.9
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
38
105
3.68
12.07
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
514
3826
1.49
12.04
4.4
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
115
566
2.10
12.03
2.7
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
109
526
2.14
11.99
4.1
3.8
g/l
0.3
0.3
0.28
53
224
(3017181) Myelocytes/100 leukocytes in Blood
196
1157
1.78
11.94
5.6
4.1
%
1.2
0.9
0.55
63
326
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
352
2420
1.57
11.93
1.3
1.3
iu/ml
32.4
32.9
0.02
89
756
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
472
3461
1.50
11.88
3.7
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
70
280
2.56
11.81
2.1
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
31
75
4.19
11.81
1.5
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
115
573
2.08
11.65
2.1
2.0
g/l
1.3
1.5
1.41
96
505
(3034860) Kappa light chains.free [Mass/volume] in Serum
88
394
2.30
11.62
4.2
3.7
mg/l
61.2
65.5
0.07
75
323
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
219
1345
1.72
11.61
3.0
2.3
u/l
31.2
73.6
0.63
188
1136
(40760888) Immunoglobulin light chains.free panel - Serum
71
289
2.52
11.56
4.2
3.9
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
88
395
2.29
11.56
4.2
3.7
mg/l
50.2
43.3
0.22
74
325
(3018095) Leukocytes [#/volume] in Urine
646
5057
1.44
11.55
5.5
3.8
e6/l
84.3
104.2
0.34
498
3526
(3024932) HLA-DR beta [Type]
23
44
5.28
11.55
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
350
2420
1.56
11.53
3.6
2.8
e6/l
1.0
1.1
0.03
206
1365
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
509
3820
1.47
11.31
3.5
3.1
ng/l
1231.8
1335.8
0.23
426
3250
(21494434) Karyotype in Bone marrow
40
120
3.39
11.26
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
146
801
1.90
11.25
1.7
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1561
14508
1.75
11.13
29.3
15.6
mmol/l
139.2
139.6
7.30
1531
14126
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
105
515
2.11
11.09
2.2
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
96
455
2.17
11.07
1.7
1.6
iu/ml
13.3
0.1
0.50
27
88
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
25
6.86
11.02
7.6
6.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
37
107
3.51
11.01
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
37
107
3.51
11.01
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
37
107
3.51
11.01
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
37
108
3.48
10.87
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
37
108
3.48
10.87
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
37
108
3.48
10.87
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1563
14549
1.74
10.85
29.8
15.7
mmol/l
4.0
4.0
0.32
1531
14135
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
76
4.00
10.77
1.1
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
582
4522
1.43
10.63
3.9
2.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
115
593
2.01
10.62
2.2
1.9
u/l
41.4
38.3
0.98
102
530
(3004119) Hemoglobin [Mass/volume] in Venous blood
145
810
1.86
10.57
11.2
3.2
g/l
125.4
127.6
0.56
140
789
(3024471) HLA-A [Type]
22
45
4.94
10.27
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
23
49
4.74
10.25
3.2
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
789
6507
1.39
10.05
18.0
9.1
e9/l
0.0
0.0
0.57
661
5280
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
327
2292
1.53
10.00
3.9
2.9
e6/l
2.9
2.9
0.05
178
1245
(3022145) Colonoscopy Study observation
237
1545
1.62
9.94
1.5
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
88
421
2.15
9.93
1.5
1.6
u/l
12.6
9.2
1.13
67
323
(3033658) Prothrombin time (PT) actual/Normal
474
3586
1.44
9.87
7.6
4.0
%
90.1
90.8
0.27
463
3490
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
72
3.94
9.87
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
72
3.94
9.87
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
40
131
3.10
9.81
3.3
2.5
—
—
—
0
0
(3019225) pH of Specimen
215
1374
1.64
9.76
6.1
4.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
34
101
3.41
9.75
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
181
2.76
9.71
1.6
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
140
797
1.82
9.61
18.5
4.3
mmol/l
24.2
23.9
0.47
127
736
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
397
2918
1.47
9.59
1.7
1.7
pmol/l
48624324.6
34227232.7
0.16
327
2425
(3025159) Blasts/100 leukocytes in Blood
171
1036
1.72
9.49
5.4
4.2
%
0.0
0.4
0.58
50
252
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
128
712
1.86
9.46
2.5
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
245
1629
1.59
9.45
8.9
6.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
98
498
2.03
9.44
6.7
2.8
%
94.1
91.7
0.40
91
469
(3008757) Leukocyte morphology finding [Identifier] in Blood
44
158
2.83
9.21
8.3
3.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1598
15071
1.75
9.20
18.6
10.1
u/l
26.0
25.6
0.27
1552
14561
(4010399)
163
983
1.73
9.19
1.5
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
23
54
4.30
9.13
1.5
1.2
%
109.6
111.9
0.15
23
46
(3023323) Follitropin [Units/volume] in Serum or Plasma
113
613
1.90
9.03
1.5
1.5
iu/l
22.5
26.3
0.64
87
507
(3052592) Norovirus Ag [Presence] in Stool
15
24
6.30
9.00
1.3
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
38
128
3.01
8.91
4.2
3.0
%
61.0
55.3
0.68
26
90
(3024522) Salmonella sp identified in Specimen by Organism specific culture
48
184
2.65
8.89
2.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
48
184
2.65
8.89
2.0
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
829
6981
1.36
8.88
5.1
3.6
estimate
0.0
0.0
0.00
144
1308
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
18
7.27
8.85
1.9
3.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
60
258
2.37
8.75
3.3
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
68
309
2.25
8.74
2.9
3.1
umol/l
35.3
34.6
0.09
59
264
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
27
74
3.69
8.73
4.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
27
74
3.69
8.73
4.2
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
51
204
2.55
8.68
2.5
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1592
15034
1.70
8.65
28.8
15.6
umol/l
75.3
74.9
0.16
1592
15029
(3025468) Yersinia sp identified in Specimen by Organism specific culture
47
182
2.63
8.54
2.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
47
182
2.63
8.54
2.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
47
182
2.63
8.54
2.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
41
148
2.81
8.52
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
86
434
2.03
8.47
1.2
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
13
8.51
8.47
1.1
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
352
2583
1.45
8.47
3.8
3.0
mmol/l
2.5
2.5
0.04
306
2278
(3005988) Vibrio sp identified in Specimen by Organism specific culture
47
183
2.61
8.45
2.0
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
321
2316
1.47
8.42
1.3
1.2
u/ml
10.8
11.7
0.08
94
865
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
85
429
2.03
8.37
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
104
565
1.89
8.29
6.1
2.4
s
21.6
21.6
0.03
94
512
(3014148) Varicella zoster virus Ab [Titer] in Serum
49
197
2.53
8.27
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
42
158
2.70
8.09
2.5
2.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
86
442
1.99
8.07
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
52
219
2.42
7.97
1.2
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
27
79
3.46
7.96
1.4
1.3
u/l
13.0
13.8
0.22
27
73
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
47
4.29
7.94
1.3
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
141
853
1.71
7.87
9.7
9.8
%
93.8
93.9
0.07
141
847
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
141
856
1.70
7.78
9.6
9.7
%
0.7
0.7
0.13
141
850
(3011397) Hemoglobin [Presence] in Urine by Test strip
427
3290
1.39
7.75
5.1
3.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
75
373
2.06
7.71
3.2
2.7
g/l
0.0
0.0
0.22
68
349
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
86
450
1.96
7.68
1.2
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
14
25
5.64
7.55
1.2
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
22
58
3.83
7.53
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
22
58
3.83
7.53
1.5
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
403
3088
1.40
7.53
5.2
4.0
kg/l
1.0
1.0
0.15
62
466
(3009261) Glucose [Presence] in Urine by Test strip
828
7088
1.32
7.44
5.2
3.7
estimate
0.0
0.0
0.80
143
1283
(3003327) Ova and parasites identified in Stool by Light microscopy
90
484
1.91
7.42
1.9
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
173
1121
1.60
7.41
4.5
3.9
ng/l
80.4
82.3
0.12
148
997
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
81
422
1.96
7.34
3.2
2.8
g/l
1.6
1.0
0.43
72
377
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
140
862
1.68
7.33
9.6
9.5
%
1.3
1.3
0.08
140
855
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
26
5.42
7.25
1.1
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
45
186
2.46
7.20
2.8
2.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
62
295
2.14
7.17
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
34
4.74
7.17
1.4
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
62
297
2.13
7.05
3.3
3.6
%
58.6
57.6
0.23
62
297
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
33
118
2.83
7.02
1.7
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
71
359
2.02
7.01
1.3
1.2
titre
131.4
82.3
—
7
31
(3017704) Immunofixation for Urine
26
81
3.24
6.98
1.8
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
816
7014
1.31
6.95
7.1
5.0
estimate
0.0
0.0
0.50
148
1332
(3030905) Polymorphonuclear cells [#/volume] in Blood
60
286
2.14
6.92
3.4
3.4
e9/l
3.9
4.2
0.59
60
286
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
120
2.78
6.82
3.4
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
120
2.78
6.82
3.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
120
2.78
6.82
3.4
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
107
625
1.76
6.79
5.2
3.1
mmol/l
25.6
25.2
0.61
102
604
(3029075) Extractable nuclear Ab panel - Serum
19
49
3.91
6.71
1.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
167
1100
1.57
6.68
5.8
4.2
%
0.1
0.1
0.22
56
297
(3004809) Band form neutrophils/100 leukocytes in Blood
48
212
2.30
6.66
3.3
3.4
%
1.9
1.4
0.38
36
172
(3022313) Gas panel - Capillary blood
127
783
1.67
6.64
7.0
5.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
45
4.03
6.63
1.3
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
118
716
1.70
6.55
7.6
5.5
mmol/l
24.7
24.8
0.12
113
681
(3017732) Neutrophils [#/volume] in Blood
151
977
1.60
6.52
3.2
2.8
e9/l
4.0
4.1
0.14
117
777
(3052851) Hemolysis interference index of Serum or Plasma
80
435
1.88
6.42
2.8
3.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
10
7
14.36
6.40
11.5
10.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
50
229
2.22
6.39
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
37
148
2.53
6.37
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
42
4.08
6.36
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
238
1707
1.46
6.35
4.7
4.3
%
33.6
32.6
0.70
163
1165
(3035637) Corticotropin [Mass/volume] in Plasma
44
193
2.31
6.22
1.6
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
158
1049
1.56
6.11
7.2
4.8
kpa
5.1
5.1
0.64
151
989
(40761535) Cells panel - Urine sediment
164
1099
1.54
6.09
4.6
3.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
10
8
12.56
6.08
6.7
4.8
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
10
8
12.56
6.08
6.7
4.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
115
708
1.67
6.06
10.7
10.3
mmol/l
24.4
24.4
0.01
110
667
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
152
1003
1.56
6.04
7.1
4.9
mmol/l
1.7
1.7
0.09
119
747
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
53
3.61
6.04
1.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
156
1040
1.55
5.93
7.1
4.8
ph
7.4
7.4
0.41
17
113
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
631
5327
1.29
5.86
5.3
3.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
41
3.93
5.72
2.6
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
389
4821
0.75
5.70
2.9
2.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
47
223
2.14
5.54
1.2
1.0
u/ml
2.4
2.6
—
7
98
(3013512) EKG study
480
3933
1.30
5.53
4.6
3.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
89
525
1.73
5.51
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
211
1520
1.44
5.50
1.7
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
32
129
2.51
5.46
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1562
14914
1.47
5.46
22.8
12.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
15
38
3.97
5.44
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
29
112
2.62
5.40
1.4
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
39
174
2.27
5.35
2.8
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
11
22
5.03
5.26
1.1
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1349
12602
1.31
5.26
6.3
5.6
mmol/mol
39.5
39.6
0.10
1235
11666
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
97
594
1.67
5.25
2.8
2.2
u/l
787.7
5098.6
3.22
32
229
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
33
138
2.42
5.23
2.5
3.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
64
351
1.85
5.06
2.9
2.7
g/l
0.0
0.0
0.00
57
329
(44813793)
28
110
2.57
5.05
1.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
64
354
1.84
4.94
2.9
2.7
g/l
0.0
0.0
0.00
57
330
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
45
221
2.06
4.89
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
57
307
1.89
4.79
4.4
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
24
4.61
4.78
2.1
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
68
388
1.78
4.76
2.8
2.6
g/l
37.3
37.7
0.25
60
343
(3024891) Influenza virus A+B Ag [Presence] in Specimen
70
403
1.77
4.75
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
151
2.28
4.74
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
71
414
1.75
4.62
1.3
1.4
ug/g
295.0
292.2
0.03
34
241
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
86
2.70
4.59
1.6
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
28
116
2.44
4.56
2.8
3.5
mu/l
17.6
27.8
0.59
28
110
(3004716) Salmonella sp identified in Stool by Organism specific culture
124
835
1.52
4.55
1.4
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
20
70
2.88
4.50
2.9
2.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
124
838
1.52
4.47
1.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
156
1105
1.45
4.46
2.6
2.4
ug/l
6.0
7.2
0.53
126
978
(3020891) Body temperature
84
519
1.65
4.44
5.1
4.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
512
4332
1.26
4.41
3.7
3.2
mmol/l
6.9
7.4
2.00
432
3664
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
119
2.38
4.33
1.3
1.3
u/ml
2.3
0.8
0.42
13
51
(3009542) Hematocrit [Volume Fraction] of Blood
1401
13254
1.29
4.30
31.0
14.8
%
38.6
39.6
3.62
969
9724
(3051651) Icteric interference index of Serum or Plasma
24
95
2.55
4.30
3.0
3.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
9
8.92
4.28
1.5
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
7
6
11.71
4.27
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
7
6
11.71
4.27
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
7
6
11.71
4.27
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
7
6
11.71
4.27
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
7
6
11.71
4.27
1.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
6
11.71
4.27
5.3
7.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
45
233
1.96
4.27
5.0
2.7
—
—
—
0
0
(3036603) Volume of Urine
24
96
2.52
4.22
1.5
1.5
ml
1994.0
1903.8
—
5
19
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
36
3.63
4.20
1.3
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
46
3.28
4.19
1.3
1.8
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
14
41
3.43
4.18
3.8
2.3
mg/l
9.8
9.8
0.00
14
35
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
91
584
1.59
4.15
6.4
3.5
%
53.0
48.8
0.79
91
575
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
25
103
2.45
4.14
2.2
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
223
1705
1.35
4.10
1.8
1.7
%
1.5
1.5
0.24
193
1505
(3009871) Measles virus Ab [Titer] in Serum
14
42
3.35
4.04
1.9
1.7
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
9
14
6.46
3.98
1.1
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
24
99
2.44
3.97
2.3
1.4
promille
1.0
1.3
0.35
19
77
(3000492) Spirometry study
181
1347
1.38
3.94
1.5
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
181
1347
1.38
3.94
4.2
4.1
ug/l
12.1
21.3
0.51
145
1101
(3017446) Testosterone [Moles/volume] in Serum or Plasma
124
862
1.47
3.93
2.1
2.1
nmol/l
11.8
12.2
0.23
109
749
(3042733) HLA Ab [Presence] in Serum
14
43
3.27
3.91
3.7
4.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
78
491
1.62
3.87
1.2
1.3
miu/ml
235.5
236.9
0.01
31
221
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
15
49
3.08
3.81
2.1
4.7
—
30.5
—
0
7
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
42
222
1.91
3.79
1.1
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
54
310
1.77
3.76
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
54
310
1.77
3.76
1.8
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
224
1737
1.33
3.75
2.2
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
243
1913
1.31
3.66
2.3
2.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
9
16
5.65
3.66
1.2
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
34
169
2.03
3.65
1.2
1.5
mosm/kgh2o
285.3
280.6
0.76
26
124
(3024928) Oxygen saturation in Venous blood
52
300
1.76
3.58
22.7
3.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
204
1573
1.34
3.56
1.7
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
225
1764
1.32
3.50
1.3
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
36
3.35
3.48
1.0
1.0
—
—
—
0
0
(4024509)
27
126
2.16
3.42
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
74
476
1.58
3.39
2.5
2.3
ug/l
2888.5
422.5
0.44
69
444
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
29
140
2.09
3.38
1.3
1.2
u/l
88.9
63.5
0.48
23
97
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
76
2.52
3.38
1.5
1.9
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
14
5.74
3.34
1.4
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
14
5.74
3.34
1.4
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
127
917
1.42
3.33
3.0
3.2
pmol/l
4.6
4.6
0.26
114
809
(3022217) INR in Platelet poor plasma by Coagulation assay
211
1653
1.31
3.30
28.9
24.6
inr
1.1
1.3
2.10
27
232
(3036071) Salmonella sp Ab [Titer] in Serum
15
54
2.79
3.25
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
27
129
2.11
3.24
3.0
2.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
102
712
1.46
3.21
3.5
2.7
e6/l
0.2
0.3
1.00
97
691
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
40
222
1.82
3.16
1.8
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
144
1074
1.37
3.13
3.3
2.6
ml/min/173m2
71.2
67.0
0.51
59
432
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
18
73
2.48
3.13
4.6
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
18
73
2.48
3.13
4.6
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
18
73
2.48
3.13
4.6
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
18
73
2.48
3.13
4.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
24
112
2.16
3.07
41.9
3.4
%
9.0
11.1
1.68
24
112
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
146
2.00
3.06
1.2
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
76
505
1.53
3.05
3.3
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
47
277
1.72
3.05
1.6
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1637
15973
1.43
3.05
38.8
20.0
e9/l
254.5
253.9
0.13
1609
15555
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
29
3.46
3.05
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
65
417
1.58
3.04
1.2
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1277
12102
1.21
3.02
33.5
16.7
%
13.9
13.6
8.26
1257
11845
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
87
2.31
3.01
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
113
2.14
3.01
1.9
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
51
2.76
2.98
3.3
4.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
450
3897
1.21
2.95
3.7
3.3
mg/l
2058.6
313.4
3.08
286
2446
(3024731) MCV [Entitic volume]
1637
15982
1.42
2.94
38.6
20.0
fl
90.7
90.6
0.10
1625
15762
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
437
1.55
2.93
2.9
3.3
u/ml
0.3
0.4
0.38
34
246
(3026361) Erythrocytes [#/volume] in Blood
1637
15984
1.42
2.92
38.7
20.0
e12/l
4.4
4.5
12.24
1604
15524
(3035941) MCH [Entitic mass]
1637
15984
1.42
2.92
38.6
19.9
pg
30.1
30.2
0.44
1625
15762
(3023410) Appearance of Cerebral spinal fluid
31
163
1.92
2.91
7.0
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
30
3.35
2.90
1.7
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
65
423
1.56
2.88
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
58
2.60
2.87
4.9
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
58
2.60
2.87
4.9
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1637
15989
1.41
2.86
38.8
20.1
e9/l
6.8
6.7
0.53
1604
15529
(3021387) Prolactin [Units/volume] in Serum or Plasma
77
522
1.50
2.84
1.6
1.5
mu/l
297.1
305.3
0.12
72
474
(3000963) Hemoglobin [Mass/volume] in Blood
1637
15992
1.41
2.83
39.0
20.2
g/l
130.9
134.6
19.74
1624
15765
(3051611) Lipemic interference index of Serum or Plasma
29
151
1.94
2.80
3.1
3.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
72
483
1.51
2.79
3.2
4.1
mmol/l
1.3
1.4
0.02
72
474
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
59
2.56
2.79
4.9
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
68
452
1.52
2.76
3.5
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
439
3816
1.20
2.75
4.5
3.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
124
928
1.36
2.68
1.4
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
20
92
2.19
2.67
1.6
1.5
g/l
1.0
1.0
0.16
20
92
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
220
1.74
2.66
1.1
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
22
106
2.09
2.63
4.2
2.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
137
1045
1.34
2.62
1.3
1.2
iu/ml
123.9
142.3
0.29
47
402
(3043409) Potassium [Moles/volume] in Arterial blood
62
409
1.53
2.61
3.4
4.2
mmol/l
3.7
3.9
1.84
62
380
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
15
4.68
2.60
1.4
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
283
1.64
2.59
1.8
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
38
222
1.73
2.58
1.2
1.2
u/ml
2.7
3.3
—
7
69
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
11
38
2.91
2.58
3.6
1.9
ng/l
96.5
121.5
0.47
11
26
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
38
2.91
2.58
1.5
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
7
7.16
2.55
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
55
356
1.56
2.53
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
86
612
1.43
2.51
3.1
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
90
650
1.41
2.43
3.0
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
117
1.98
2.41
1.7
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
464
4099
1.18
2.39
4.3
4.0
mg/mmol
8.0
8.7
0.15
290
2555
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
90
2.12
2.39
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
146
1.86
2.38
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
8
6.26
2.37
1.2
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
5
8
6.26
2.37
7.4
2.3
mg/l
2.3
4.9
—
5
8
(3016018) Differential panel - Cerebral spinal fluid
28
154
1.83
2.34
4.9
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1401
13491
1.20
2.33
5.2
4.4
mmol/l
5.9
5.9
0.08
1272
12277
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
52
340
1.55
2.31
4.8
1.5
e6/l
7.6
35.9
0.87
40
258
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
52
340
1.55
2.31
4.8
1.6
e6/l
68.7
946.8
1.33
40
271
(3027008) Opiates [Presence] in Urine
90
657
1.39
2.30
3.0
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1026
9648
1.15
2.28
4.5
3.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
72
2.23
2.27
4.9
2.0
mmol/l
9.3
9.5
—
8
57
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
113
1.96
2.25
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
74
524
1.43
2.25
1.6
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
90
660
1.38
2.24
3.0
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
29
3.11
2.22
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
115
878
1.33
2.22
2.1
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
35
210
1.68
2.20
7.5
2.6
u/ml
24.8
26.3
0.02
35
195
(3048879) Bone marrow aspiration report
10
36
2.79
2.20
2.2
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
80
2.14
2.19
1.3
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
47
305
1.56
2.18
3.6
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
88
647
1.38
2.17
3.0
1.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
16
74
2.17
2.15
5.9
6.2
u/ml
57.2
64.3
—
5
20
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
30
3.01
2.14
1.0
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
21
109
1.94
2.10
5.2
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
72
515
1.42
2.09
1.5
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
31
2.91
2.07
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
51
342
1.51
2.05
1.5
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
20
3.51
2.05
3.6
1.4
ng/l
173.4
88.3
—
7
20
(3006653) Thiamine [Moles/volume] in Blood
15
69
2.18
2.04
2.1
1.3
nmol/l
149.4
149.0
0.01
15
69
(3034274) Bile acid [Moles/volume] in Serum --fasting
33
200
1.66
2.02
3.9
2.6
umol/l
8.0
7.0
0.17
27
145
(3051593) INR in Capillary blood by Coagulation assay
12
50
2.41
2.02
1.0
13.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
90
2.01
2.00
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
36
224
1.62
2.00
1.3
1.2
u/l
145.6
33.5
0.99
31
192
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
32
2.82
2.00
1.7
1.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
63
446
1.43
1.95
2.3
1.8
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
11
4.56
1.94
1.2
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
172
1.70
1.93
3.5
2.7
—
—
—
0
0
(3035880) pH of Pleural fluid
15
71
2.12
1.92
1.4
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
58
2.25
1.91
1.6
1.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
65
2.16
1.88
2.6
3.7
umol/l
192.3
148.3
—
6
43
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
22
3.19
1.88
1.0
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
9
34
2.66
1.86
1.0
1.1
mmol/l
2.2
3.4
—
9
28
(3005011) Chlamydia sp Ab [Titer] in Serum
8
28
2.87
1.86
1.3
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
221
1.60
1.85
1.2
1.2
u/ml
3.0
6.0
1.05
12
91
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
160
1.70
1.82
2.1
2.4
mg/l
36.4
30.0
—
10
47
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
183
0.43
1.81
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
29
2.77
1.79
1.1
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
29
2.77
1.79
1.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
29
2.77
1.79
1.1
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
405
1.42
1.76
1.6
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
415
3717
1.15
1.76
5.9
3.9
estimate
0.0
0.0
1.28
144
1282
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
28
172
1.64
1.67
1.5
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
67
495
1.37
1.66
4.5
3.3
u/ml
202.9
2918.1
0.75
60
427
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
19
3.17
1.66
1.5
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
25
2.81
1.65
5.0
10.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
132
0.38
1.62
1.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
14
3.58
1.61
1.0
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1347
13042
1.15
1.60
4.4
3.8
mmol/l
1.3
1.3
0.69
1227
11939
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
77
1.96
1.59
1.1
1.1
ratio
1.1
1.1
—
5
32
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
26
2.70
1.58
1.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
231
1.53
1.57
1.0
1.1
—
—
—
0
0
(4306422)
32
207
1.56
1.57
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
57
2.11
1.55
1.2
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
27
2.60
1.51
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
133
1094
1.23
1.50
2.3
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
37
251
1.48
1.48
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1352
13119
1.14
1.46
19.6
12.6
ml/min/173m2
84.1
82.5
1.71
1139
10659
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
277
1.45
1.45
2.9
3.2
nmol/l
0.7
0.8
1.37
26
221
(40768446) Kidney Pathology biopsy report
12
59
2.04
1.43
1.7
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
164
1.59
1.43
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
37
253
1.47
1.43
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
53
2.08
1.38
1.0
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6
23
2.61
1.37
1.5
1.3
—
17.8
—
0
5
(3006184) Hemoglobin [Mass/volume] in Capillary blood
43
307
1.41
1.35
2.6
2.1
g/l
127.7
130.3
0.23
31
233
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
42
2.15
1.33
4.8
8.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
9
42
2.15
1.33
1.3
1.5
—
6.5
—
0
9
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
68
1.92
1.33
2.2
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
41
292
1.41
1.31
5.3
3.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
15
84
1.79
1.27
1.3
1.5
ug/l
6.6
6.8
0.04
15
70
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
162
1.55
1.26
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
36
2.23
1.24
1.3
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1265
12268
1.11
1.23
35.9
17.5
g/l
331.9
332.4
1.17
1260
12180
(3012501) Base excess in Blood by calculation
41
297
1.39
1.21
6.0
4.4
mmol/l
2.1
2.7
0.91
22
198
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
309
0.64
1.16
1.2
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
39
2.06
1.15
5.3
8.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
20
2.50
1.15
1.4
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
20
2.50
1.15
6.4
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
87
1.73
1.15
1.0
1.1
—
—
—
0
0
(4268621)
23
150
1.54
1.14
2.5
2.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
21
134
1.57
1.14
3.3
4.5
u/ml
412.5
47.0
—
10
37
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
271
2434
1.13
1.12
1.5
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
34
242
1.41
1.12
1.1
1.1
u/ml
5.3
4.4
0.09
13
103
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
21
2.38
1.09
1.2
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
41
1.96
1.09
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
372
3413
1.11
1.08
4.8
4.9
ug/l
2.8
2.7
0.06
340
3037
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
32
2.19
1.08
4.7
3.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
59
1.87
1.07
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
59
1.87
1.07
1.5
1.9
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
31
219
1.42
1.07
1.5
1.5
nmol/l
0.5
0.3
0.55
23
175
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
302
0.66
1.06
1.2
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
113
1.60
1.05
1.9
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
33
2.13
1.05
1.0
1.0
mg/g
5.2
6.2
—
7
33
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
33
2.13
1.05
2.3
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
33
2.13
1.05
1.1
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
67
1.80
1.04
1.2
1.1
iu/ml
101.5
249.9
1.77
12
67
(3005033) Fetal Nuchal fold Thickness US
20
300
0.66
1.04
1.2
1.4
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
5
22
2.28
1.03
1.2
1.1
—
46.8
—
0
9
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
47
1.92
1.02
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
47
1.92
1.02
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1396
13658
1.11
1.01
4.8
4.3
mmol/l
4.6
4.7
2.49
1293
12659
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
47
360
1.31
1.01
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
48
1.88
1.00
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
35
2.00
1.00
1.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
27
189
1.44
0.99
1.3
1.4
u/l
22.8
23.5
0.04
19
154
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
50
1.80
0.96
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
93
780
1.20
0.95
3.7
3.2
u/ml
79.9
52.5
0.21
85
746
(21494755) Public health laboratory ask at order entry panel
106
1242
0.84
0.94
1.3
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
19
125
1.53
0.94
1.1
1.4
e6/l
173909.3
158691.7
—
10
84
(3024869) Neuronal Ab [Presence] in Serum
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
435
4055
1.10
0.93
1.5
1.5
—
—
—
0
0
(4146454)
22
151
1.46
0.90
3.0
2.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
63
1.75
0.90
1.5
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
29
2.07
0.89
1.8
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
160
1413
1.15
0.88
4.0
3.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
43
333
1.30
0.88
1.8
1.7
nmol/l
39.4
40.0
0.06
43
319
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
79
1.65
0.88
4.8
6.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
45
351
1.29
0.88
1.1
1.1
u/ml
1.5
2.3
0.28
16
166
(4027681)
16
103
1.56
0.87
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
72
1.67
0.85
1.4
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
17
112
1.52
0.85
2.2
3.3
mg/l
6.1
34.5
1.44
11
83
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
31
1.94
0.84
2.7
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
96
1.57
0.84
1.1
1.2
u/ml
1.0
3.1
—
5
45
(3044007) Cell count panel - Peritoneal fluid
8
45
1.78
0.84
1.3
2.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
38
293
1.30
0.82
5.7
2.9
mmol/l
1.4
1.5
0.53
38
285
(3003888) Timothy IgE Ab [Units/volume] in Serum
41
320
1.29
0.81
1.1
1.1
u/ml
6.8
5.6
0.16
21
187
(3038515) Glucose [Moles/volume] in Venous blood
36
276
1.31
0.81
5.3
3.0
mmol/l
7.6
7.5
0.07
36
269
(3047007) Chlamydophila sp Ab [Presence] in Serum
30
224
1.35
0.80
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
58
1.73
0.79
2.7
3.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
25
0.00
0.79
0.0
1.1
—
1.8
—
0
25
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
98
1.54
0.78
1.2
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
74
1.63
0.78
1.3
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
165
1.40
0.78
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
165
1.40
0.78
1.7
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
115
1.48
0.77
1.8
2.2
u/field
0.6
2.2
—
8
51
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
99
1.52
0.75
1.2
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
91
1.54
0.75
1.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
396
3714
1.09
0.74
1.9
1.7
mmol/l
1.5
1.4
0.56
346
3135
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
11
68
1.62
0.71
1.0
1.1
—
13.2
—
0
10
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
57
1.58
0.71
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
221
1.32
0.70
1.1
1.1
u/ml
1.2
7.0
3.20
13
95
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1412
13893
1.09
0.69
5.2
4.7
mmol/l
2.7
2.8
3.02
1300
12796
(40768806) Pleura Pathology biopsy report
19
135
1.41
0.69
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
213
1.32
0.68
1.5
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
215
0.70
0.67
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
28
214
1.31
0.67
1.2
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
39
312
1.26
0.66
1.2
1.1
u/ml
0.6
1.4
0.60
17
156
(3001686) Cold agglutinin [Titer] in Serum or Plasma
5
28
1.79
0.66
1.0
1.2
—
223.2
—
0
5
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
316
0.76
0.65
3.5
3.6
mg/l
28.5
25.1
0.16
15
201
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1378
13556
1.08
0.64
4.8
4.2
mmol/l
1.5
1.5
0.06
1272
12488
(4034850)
35
437
0.80
0.64
13.5
10.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
40
323
1.24
0.64
1.7
1.7
e6/l
13967.4
12699.6
0.05
28
236
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
29
1.73
0.64
5.2
2.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
62
727
0.85
0.61
1.4
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
125
1119
1.13
0.61
5.9
3.5
mmol/l
1.2
1.2
0.06
112
969
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
31
244
1.28
0.61
1.2
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
50
1.60
0.61
1.8
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
32
253
1.27
0.61
1.8
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
32
254
1.26
0.59
5.2
2.4
—
—
—
0
0
(4211845)
10
64
1.57
0.58
2.6
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
108
1207
0.89
0.57
1.9
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
115
1.39
0.56
1.6
1.5
%
33.9
32.3
—
9
72
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
166
1521
1.10
0.55
1.6
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
99
1.42
0.54
1.0
1.1
u/l
1.4
1.1
—
5
49
(3012565) Volume of 24 hour Urine
9
61
1.48
0.53
2.4
2.5
ml
1697.8
1861.2
—
9
56
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
64
1.41
0.51
2.1
4.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
64
1.41
0.51
1.1
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
289
2723
1.07
0.51
4.2
4.2
%
21.0
21.1
0.03
119
1266
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
35
421
0.83
0.49
1.4
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
44
372
1.19
0.49
5.3
3.1
mmol/l
24.9
24.9
0.01
37
328
(3020491) Glucose [Moles/volume] in Blood
15
110
1.37
0.48
2.4
1.6
mmol/l
9.0
6.6
—
10
70
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
47
1.49
0.47
2.6
2.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
68
1.47
0.47
1.1
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
129
1.32
0.45
1.4
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
50
1.40
0.45
1.3
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
21
165
1.28
0.45
1.5
1.7
%
56.5
59.6
0.13
14
109
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
112
1.34
0.44
2.1
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
220
1.23
0.43
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
56
489
1.15
0.43
2.5
2.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
56
1.43
0.42
1.1
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
122
1.31
0.42
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
32
1.56
0.42
1.6
2.2
umol/l
13.5
16.8
—
5
32
(3016031) Almond IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
1.3
—
0
11
(3011048) Pyruvate [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.3
—
97.4
—
0
17
(3004451) EKG impression Narrative
8
60
1.33
0.40
1.6
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
35
1.43
0.39
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
32
378
0.84
0.39
1.3
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
19
0.00
0.39
0.0
8.5
—
6.9
—
0
19
(3009015) Lactate [Moles/volume] in Synovial fluid
0
19
0.00
0.39
0.0
1.4
—
6.1
—
0
11
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
32
377
0.85
0.38
1.3
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
44
382
1.16
0.38
2.1
1.8
iu/l
3.9
4.6
0.33
18
131
(3017569) Oxygen content in Arterial blood
9
66
1.37
0.38
2.4
3.0
—
—
—
0
0
(4198724)
9
68
1.33
0.37
3.6
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
32
376
0.85
0.37
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
32
376
0.85
0.37
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
76
839
0.90
0.37
1.6
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
112
1212
0.92
0.36
5.7
3.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
71
1.27
0.36
1.4
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
292
1.17
0.34
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
44
1.36
0.34
1.3
2.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
25
209
1.20
0.34
1.1
1.1
u/ml
0.0
0.4
—
7
63
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
209
1.20
0.34
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
275
0.83
0.33
1.8
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
118
1.27
0.33
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
187
1975
0.94
0.33
2.8
3.0
ug/l
0.6
0.8
1.72
121
1272
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
22
183
1.20
0.31
1.6
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
30
348
0.86
0.31
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
35
305
1.15
0.31
1.1
1.1
u/ml
0.6
2.0
1.58
11
81
(3033705) Calcium.ionized [Moles/volume] in Venous blood
20
166
1.21
0.30
4.2
2.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
8
109
0.73
0.29
1.6
1.7
mmol/l
7.0
7.4
—
8
67
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
53
480
1.11
0.27
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
60
548
1.10
0.26
1.1
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
14
113
1.24
0.26
2.2
1.9
—
1.7
—
0
8
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
319
1.13
0.26
2.5
2.4
ug/min
63.7
93.2
0.41
12
198
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
38
338
1.13
0.26
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
2.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
235
1.15
0.25
1.2
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
34
302
1.13
0.24
3.2
2.1
nmol/l
0.9
0.8
0.18
29
254
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
78
1.28
0.24
2.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
27
307
0.88
0.23
1.6
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
171
1.17
0.23
1.7
1.3
nmol/l
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
38
1.32
0.23
3.2
3.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
32.2
—
0
10
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
69
644
1.07
0.20
2.2
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
31
345
0.90
0.20
2.8
2.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
164
1.16
0.20
1.9
1.4
pmol/l
284.8
302.3
0.11
13
127
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
60
1.17
0.17
2.3
2.1
ug/l
27.9
155.3
—
7
52
(3012441) Differential panel - Pleural fluid
15
129
1.16
0.17
1.9
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
76
0.79
0.15
1.8
2.1
ug/l
2.6
2.1
—
6
63
(3006442) Creatine [Moles/volume] in Serum or Plasma
12
102
1.18
0.15
1.8
1.4
—
65.4
—
0
8
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
29
265
1.10
0.14
1.2
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
93
1.18
0.14
1.9
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
106
0.85
0.13
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
19
210
0.90
0.12
1.4
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
67
701
0.95
0.12
2.0
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
31
288
1.08
0.11
3.5
2.3
%
16.5
16.4
0.08
20
150
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
51
484
1.06
0.11
1.4
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
38
358
1.06
0.10
7.0
4.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
47
1.06
0.09
1.0
1.2
%
—
12.4
—
0
7
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
1.8
2.1
mmol/l
2.8
2.0
—
5
36
(4094501)
38
360
1.06
0.09
1.2
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.3
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
3.3
2.4
umol/l
53.6
48.7
—
7
52
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
72
0.83
0.07
1.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
80
0.87
0.07
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
96
937
1.03
0.07
3.9
2.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
109
1.10
0.06
1.4
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
48
465
1.03
0.05
1.6
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
102
1.08
0.03
2.0
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
24
231
1.04
0.02
1.1
1.1
iu/ml
1.0
170.0
—
5
54
(3000330) Specific gravity of Urine by Test strip
73
721
1.01
0.01
5.4
3.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
134
1.05
0.00
1.4
1.4
mmol/l
12.7
11.7
—
5
29
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
164
1.04
0.00
1.9
2.2
pg
33.4
32.3
0.40
17
164
(3045788) Cell count panel - Pleural fluid
12
119
1.01
0.00
1.5
1.4
—
—
—
0
0
(4281824)
16
158
1.01
0.00
1.2
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
58
0.86
0.00
1.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
22.1
—
0
9
(40765089) Chromosome analysis panel - Blood by G-banded
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
36.0
—
0
9
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
25.1
—
0
9
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
8.3
—
0
9
(3049233) Organic acids panel - Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.8
—
0
5
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
85
0.94
0.00
2.0
2.2
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
180.1
—
0
8
(3043410) Blood group antigens tested for on Red Blood Cells
5
56
0.89
0.00
1.4
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
4.7
—
0
6
(3044242) Glucose [Moles/volume] in Arterial blood
7
77
0.91
0.00
2.7
2.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
81
0.99
0.00
1.0
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
173.0
—
0
6
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.0
—
6.2
—
0
10
(3000012) Reticulocyte production index
7
71
0.99
0.00
1.0
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
63
0.95
0.00
1.2
1.1
miu/ml
832.2
1596.2
—
6
63
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
6
66
0.91
0.00
1.0
1.0
mmol/l
20.0
19.6
—
6
60
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
56
560
1.00
0.00
2.0
1.7
mg/l
4.5
4.0
0.12
37
401
Mortality – FinRegistry
↥Association
Association between endpoint K11_APHTA_RECUR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_APHTA_RECUR | 1.617 [1.45, 1.81] | < 0.001 |
| Birth year | 1.002 [0.99, 1.01] | 0.593 |
During the follow-up period (1.1.1998 — 31.12.2019), 1293 out of 7066 females with K11_APHTA_RECUR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_APHTA_RECUR | 2.015 [1.74, 2.33] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 941 out of 5520 males with K11_APHTA_RECUR died.
Mortality risk
Mortality risk for people of age
years, who have K11_APHTA_RECUR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.176% | 0.405% |
| 5 | 1.058% | 2.218% |
| 10 | 2.973% | 5.759% |
| 15 | 5.92% | 10.736% |
| 20 | 10.087% | 17.544% |
Relationships between endpoints
↥Index endpoint: K11_APHTA_RECUR – Recurring oral aphthae
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data